Company intelligence / Profile preview

Sobi Analytics

Stockholm, Sweden

Ownership: Private
Employees: ~1800
Development stage: Other

Overview

Sobi (Swedish Orphan Biovitrum) is a leading international biopharmaceutical company dedicated to transforming the lives of people living with rare diseases. The company focuses on two primary therapeutic areas: Hematology and Immunology, with a growing presence in Specialty Care. Sobi's portfolio includes market-leading treatments for hemophilia, such as Elocta and Alprolix, as well as innovative therapies for inflammatory and genetic conditions like Kineret and Gamifant. Through strategic partnerships with companies like Sanofi and Apellis, Sobi continues to expand its pipeline and global reach.

Therapeutic areas: HematologyImmunologyInfectious Diseases
Modalities: Recombinant proteinMonoclonal antibodySmall moleculePeptides
Industry: Biotech

Partnerships

SanofiApellis PharmaceuticalsAstraZenecaSelecta Biosciences

Beyond the preview

Go deeper on Sobi Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sobi Analytics.

Explore the full profile